SCHEMBL1072162

SCHEMBL1072162

COc1cc(F)c(-c2c(Cl)nc(C=O)n2-c2ccc(F)cc2)c(F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
ALDH1A1 P00352 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
NPBWR1 P48145 1/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
TP53 P04637 1/20 0.33
NQO2 P16083 1/20 0.33
USP2 O75604 1/20 0.33
GLA P06280 1/20 0.33
HSP90B1 P14625 1/20 0.33
TRAP1 Q12931 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
PIK3CA P42336 1/20 0.33
CYP19A1 P11511 1/20 0.33
EGFR P00533 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1072094 0.85 KDM4E (0.40) PTGS1PTGS2ALDH1A1NPSR1NPBWR1
SCHEMBL1072091 0.85 KDM4E (0.40) PTGS1PTGS2ALDH1A1NPSR1NPBWR1
SCHEMBL1225381 0.83 PIK3CA (0.42) PTGS1PTGS2ALDH1A1NPSR1NPBWR1
SCHEMBL1074415 0.80 CYP19A1 (0.38) PTGS1PTGS2ALDH1A1NPSR1NPBWR1
SCHEMBL1074206 0.79 LMNA (0.35) PTGS1PTGS2ALDH1A1HSP90B1TRAP1
SCHEMBL1110867 0.77 PIK3CA (0.40) PTGS1PTGS2ALDH1A1NPSR1IDO1
SCHEMBL1074799 0.77 GLA (0.39) PTGS1PTGS2NPSR1IDO1TDO2
SCHEMBL1073735 0.76 SMN1; SMN2 (0.41) IDO1TDO2GLAPIK3CAEGFR
SCHEMBL1076571 0.76 SMN1; SMN2 (0.38) PTGS1PTGS2ALDH1A1NPSR1IDO1
SCHEMBL19953120 0.74 USP2 (0.38) PTGS1PTGS2ALDH1A1NPSR1NPBWR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011056463-A2 FUNGICIDAL MIXTURES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-05-12 WO disclosed
US-20110045101-A1 FUNGICIDAL SUBSTITUTED AZOLES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-24 US disclosed
EP-2274284-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. Du Pont de Nemours and Company (US) 2011-01-19 EP disclosed
WO-2009137538-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-11-12 WO disclosed
WO-2009137651-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110045101-A1 FUNGICIDAL SUBSTITUTED AZOLES CBR3, NOX3, CBR1 PTGS1 3823/4885PTGS2 3691/4885ALDH1A1 2522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.